Francinny Alves Kelly/X
Nov 14, 2026, 14:08
Francinny Alves Kelly: AHA Scientific Sessions 2026 Features Research on CHA₂DS₂-VASc and Transhepatic AF Ablation
Francinny Alves Kelly, Physician, Research Fellow at BIDMC CVI, shared a post on X:
“Proud to represent the BIDMC CVI EP group at Scientific Sessions 26 with two moderated poster presentations on CHA₂DS₂-VASc in the contemporary anticoagulation era and transhepatic access for AF ablation.
Grateful to Andre d’Avila and our coauthors for their support!”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 15:07Vaidehi Prasanth: Patient Blood Management in Hematological Patients A New Book Chapter
-
Nov 14, 2026, 15:00Ram Mohan Jaiswal: International Collaboration in Transfusion Medicine Through the Trans Med Africa Consortium
-
Nov 14, 2026, 14:48Jamie Sin Ying Ho: Stopping Anticoagulation After AF Ablation and Rhythm Control
-
Nov 14, 2026, 14:29Satya Prakash: Cell-Free Hemoglobin-Based Oxygen Carriers and Their Clinical Development
-
Nov 14, 2026, 14:24Adela Castro: Distinguishing Antiphospholipid Antibodies From APS in Pregnancy
-
Nov 14, 2026, 14:20Uzima Chirwa: Rethinking Comprehensive Care for Bleeding Disorders in Africa
-
Nov 14, 2026, 14:19Samuele Ferrari: Launching a New Era in Hematopoietic Genome Editing Research
-
Nov 14, 2026, 14:17Stefan Hofer: International Training in Postpartum Hemorrhage Management
-
Nov 14, 2026, 14:14Expanding Global Access to Gene Therapy – WFH